Arthroscopy Procedures and Products Market Huge Growth Opportunity between 2021-2031

ESOMAR-certified consulting firm Future Market Insights, in its updated report, projects a steady growth of the arthroscopy procedures and products market between 2021 and 2031. The market is expected to reach a valuation of approx. US$ 6488.4 Mn in 2021.

Due to the non-invasive nature and benefits of arthroscopy, patients suffering from severe osteoarthritis are preferring knee arthroscopy, which is accelerating the market growth.

Rising prevalence of knee osteoarthritis among geriatric population and increasing number of knee arthroscopy conducted worldwide have augmented the market growth. Increasing application in sports medicine, and ease in regulatory approval such as the U.S. Food & Drug Administration are the factors driving growth.

Growing incidence of osteoarthritis across the U.S., Germany, the UK, and China have propelled the adoption of knee arthroscopy surgeries in those regions.

With such rising statistics, healthcare professionals and government are increasing the initiatives to provide rehabilitation and facilities to curb the additional cost. Based on such factors, the market is anticipated to witness healthy growth at over 7.7% CAGR during 2021 and 2031.

However, increasing risk of edema and other infections such as blood clots in the joints might restrict the market growth. Also, high cost of surgery and procedures across low economies such as Brazil, India and other countries in Latin America will hamper the market growth.

To remain ahead of your competitors, request for a sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-1386

Key Takeaways from FMI’s Arthroscopy Procedures and Products Market Study

  • In terms of procedure type, knee arthroscopy will account for over 50% of the global market share
  • Arthroscopic implants segment will account for highest share of the arthroscopy procedures & products market during the forecast period
  • The U.S. will emerge as the most lucrative market backed by the rising prevalence of degenerative disease among geriatric population
  • Germany and the U.K., collectively, will emerge as the most lucrative market across Europe in the upcoming decade
  • Japan is anticipated to emerge as a lucrative market backed by the high prevalence of rheumatoid arthritis and osteoarthritis among elderly

Competitive Landscape

Prominent players in the market are focusing on strategic mergers and collaboration to expand their global footprint in the market.

New product launches coupled with increasing research & development activities for the development of advanced arthroscopy instruments & devices will also be one of the key strategy to enhance their customer base for market players.

For instance, couple of years back, leading player, Smith & Nephew entered into a distribution agreement with OrthAlign, a U.S. based private company to develop medical devices and distribute their Total-Knee Arthroplasty (TKA) technology across several countries in Africa and Middle East.

Also, in 2018, Ceterix® Orthopedics, Inc., a leader in the development of cutting-edge surgical tools for orthopedic surgeons announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of NovoStitch® Pro Meniscal Repair System – a size 0 suture cartridge – offering surgeons more options to repair meniscal tears for arthroscopic surgeries.

Key Players

  • Arthrex Inc.
  • CONMED Corporation
  • Johnson & Johnson
  • KARL STORZ GmbH & Co. KG
  • Olympus Corporation
  • Richard Wolf GmbH
  • Stryker Corporation
  • Others

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-1386

More Insights on the Global Arthroscopy Procedures and Products Market

In its new offering, Future Market Insights, offers incisive coverage on global arthroscopy procedures and products market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is classified on the basis of products type (arthroscopes & visualization systems, arthroscopic resection systems, arthroscopic fluid management systems, arthroscopic implants, arthroscopy radiofrequency (RF) systems, arthroscopic drills & fixation systems, and others), and procedure type (shoulder arthroscopy, hip arthroscopy, knee arthroscopy, elbow arthroscopy, small joints arthroscopy, and others) across major regions (North America, Latin America, Eastern Europe, Asia Pacific excluding Japan, Western Europe, Japan and Middle East & Africa)

Key Points Covered in Arthroscopy Procedure and products Market Study

  • Market estimates and forecast 2021-2031
  • Key drivers and restraints impacting market growth
  • Segment-wise, Country-wise, and Region-wise Analysis
  • Competition Mapping and Benchmarking
  • Brand share and Market Share Analysis
  • Key Product Innovations and Regulatory Climate
  • COVID-19 Impact on Arthroscopy Procedure and products tools market and How to Navigate
  • Recommendation on Key Winning Strategies

Arthroscopy Procedure and Product Market by Category

By Product Type:

  • Arthroscopes and Visualization Systems
  • Arthroscopic Resection Systems
  • Arthroscopic Fluid Management Systems
  • Arthroscopic Implants
    • Knee Implants
    • Shoulder Implants
    • Hip Implants
    • Other Implants
  • Arthroscopy Radiofrequency (RF) Systems
  • Arthroscopic Drills and Fixation Systems
  • Other Arthroscopy Instruments and Accessories

By Procedure Type:

  • Shoulder Arthroscopy
  • Hip Arthroscopy
  • Knee Arthroscopy
  • Elbow Arthroscopy
  • Small Joints Arthroscopy
  • Others

For in-depth insights, Download a PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1386

By Region:

  • North America
  • Latin America
  • Eastern Europe
  • Western Europe
  • Asia Pacific excluding Japan
  • Japan
  • Middle East and Africa (MEA)

Global Empty Capsules Market Will Cross US$ 2 Bn In 2022

Empty capsules are witnessing an adoption upsurge, owing to numerous factors such as limited number of competitors, growing demand from the pharmaceutical sector, standard margin level, and potential opportunities in vegan gelatin-based capsules. Further, faster uptake by the FDA and focus of market players on ramping up production capacity are key factors shaping the growth of the empty capsules market.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-782

Empty capsule manufacturers are progressively targeting specialty markets such as contract manufacturers, generic manufacturers, and pediatric drug manufactures. Increasing penetration of low-cost manufacturers in various countries, and supply contracts of life-saving essential drugs, primarily in developing and emerging countries, are further driving the empty capsules market.

The global empty capsules market is estimated to be valued at US$ 1.9 Bn in 2020, with the market expected to exhibit a CAGR of 8% during the forecast period (2020-2030). The coronavirus (COVID-19) pandemic that has so far claimed the lives of over 200,000 people and infected over 3 million, has forced several countries to declare nationwide lockdowns. This has disturbed supply chains in the empty capsules market, due to logistics paralysis. As such, the market is expected to witness a gradual decline in in 2020.

“Lower labour cost and abundant availability of raw materials are among the key factors driving the empty capsules market in Asia Pacific excluding Japan (APEJ) and Western Europe. In addition, favorable regulatory ecosystem to establish empty capsule manufacturing businesses and lower taxation policies are propelling market growth in APAC.”

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-782

Key Takeaways of Empty Capsules Market Study

  • Greater focus on relieving pressure of supply chain due to demand gap is being tackled by ramping up production capacity; up-scaling is the fundamental strategy outlined for meeting demand in the empty capsules market.
  • Vegetable capsules are the latest innovation and are expected to replace gelatin-based variants. Recently, hard gelatin manufacturers have begun increasing the production of vegetarian capsules at scale.
  • South and East Asian pharmaceutical markets are expected to grow at twice the global average in terms of value, owing to population growth, rising incomes, and improved access to healthcare.
  • The empty capsules market in China is anticipated to exhibit the fastest growth, where per capita spending is anticipated to increase by over 70% in the coming five years.
  • High upfront costs and lower margin levels in empty capsules have resulted in 10%-20% price hike in finished products, registering lower sales for animal-based gelatin products in the recent past.
  • India, with almost 40% growth, is offering value-capture opportunities, owing to good patient recruitment, acceptable quality of services, reasonable cost-quality ratio, existence of regulatory agencies, high standards of care, larger population base, and low cost of labour.
  • Companies manufacturing halal capsules are obtaining halal certification from the Islamic Food and Nutrition Council of America (IFANCA) to capture market shares in Muslim-dominated countries.
  • The empty capsules market is consolidated, with leading manufacturers holding around 70% revenue share. Further, growing prominence of CMOs and large-scale gelatin manufacturers is anticipated to boost the growth engine.
  • Higher volume handling by key players in comparison with local manufacturers, and higher production capabilities and price advantages over non-standard manufacturers, are expected to generate significant revenue pockets.

Ask Us Your Questions About This Report:
https://www.futuremarketinsights.com/ask-question/rep-gb-782

Key Players Focus on Capacity Expansion, Strategic Acquisitions, and Joint Ventures to Widen Regional Presence

Leading players in the empty capsules market, such ACG Worldwide, Capsugel, Qualicaps, Inc., Bright Pharma Caps, Inc., and Roxlor LLC, are concentrating on business expansion through mergers, joint ventures, distribution agreements, and capturing untapped market potential.

  • For example, in 2015, Capsugel increased the production of vegetarian-based capsules by investing US$ 25 Mn across its manufacturing sites.
  • Empty capsule manufacturers are generating high returns from nutraceutical and pharmaceutical industries by supplying non-animal or vegetarian empty capsules, with effective physical properties such as reduced moisture content, best suited for nutrient supplements and hygroscopic drugs.
  • In similar context, empty capsule manufacturers are boosting substantial sales revenue from nutraceutical manufacturers by supplying vegetarian-based empty capsules coupled with fluid filling technology.
  • Top manufacturers of hard gelatin capsules are expanding their production facilities through acquisitions.
  • For instance, Qualicaps completed the acquisition of Genix Industria Farmaceutica Ltd., one of Brazil’s top hard empty capsule manufacturers. The acquisition permits the manufacturer to establish its operating sites in the U.S., Canada, Spain, Japan, and Romania.

Global Contract Manufacturing/ Contract Development And Manufacturing Organization (CMO/ CDMO) Market To Surpass US$ 18 Bn By 2020

An increasing number of companies within the pharmaceutical sector have been considering contract manufacturing in response to the increasing demand for generic drugs and biologics. In a new study, Future Market Insights (FMI) has forecast the global contract manufacturing/ contract development and manufacturing organization (CMO/ CDMO) market to surpass US$ 18 Bn by 2020.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-13038

According to the study, contract manufacturing accounts for 3/4th of all the CMO and CDMO services. Focus towards cost management, enhanced process flow, and better scalability will drive the market over the forecast period. Besides this, the increasing demand for skin care products, which also accounts for the leading share in terms of product type, will enable the market gain impetus in the coming years.

Currently an increasing number of consumers are shifting towards locally sourced and natural products rather than big brands. Achieving this will require state-of the-art technology besides other resources. As a result an increasing number of pharmaceutical companies are seeking services of contract manufacturing / contract development and manufacturing organization (CMO/CDMO).

Ask Us Your Questions About This Report:
https://www.futuremarketinsights.com/ask-question/rep-gb-13038

Key Takeaways from CMO/CDMOs Market Study

  • CMO/ CDMO services has become highly sought-after in pharmaceutical and beauty industries. FMI has projected the market to report 6.2% CAGR between 2020 and 2030
  • The U.S. is expected to account for over 77% of sales in North America by 2030
  • The U.K. will represent impressive scope for expansion, exhibiting above 7% CAGR through the forecast period
  • The rising focus on healthcare and wellness spending will support growth in Germany and France
  • The availability of inexpensive labor and resources will continue supporting growth in China. However, Japan and South Korea markets are expected to register higher percentage of growth over the forecast period

“Manufacturers operating in the market are keen on forging strategic partnerships with leading cosmetics brands and pharmaceutical companies. Collaborations are expected to remain a primary strategy adopted by market players to gain competitive edge,” says FMI analyst

In terms of the effect of COVID-19 pandemic on the demand of CMO/CDMO services, there was a negative impact on the market growth. One of the major issues was related to the supply chain gap. Prior to COVID-19, contract manufacturing was one of the most preferred sectors in the growing beauty and personal care industry. However, due to the pandemic, the industry suffered major setbacks as expected product launches were delayed. A shift was observed in consumer habits. Reduction of sales of leading products was recorded along with production slowdowns, which caused overhead to curb the profitability.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-13038

Who is Winning?

Collaboration is the key strategy amongst market players. The CMO/CDMO companies continue to focus on collaborations to gain sustainability in the market.

  • For instance, In February 2021, Lonza signed an agreement to divest its specialty ingredients business to Bain Capital and Cinven, aiming to refocus as a pure-play partner to the healthcare industry.
  • In 2021, Pierre Fabre Group hosted a pioneering custom online partnering forum, partnering with biopharmaceutical firms aiming to accelerate the digital transformation of Pierre Fabre Group
  • In 2020, In March 2020, Pierre Fabre Group, in partnership with numerous hospitals in the Occitania region of France, donated hand care creams, body cleansing gels and thermal spring water sprays and hand sanitizers necessary to combat the spread of Covid-19.

Surface Plasmon Resonance Market increasing at a decent CAGR of 6% over the forecast period of 2021- 2029

Increasing adoption of label-free detection techniques over labelled detection techniques is due to their cost-effective nature. Additionally, the availability of versatile products coupled with surface plasmon resonance to enhance the specificity of tests is an important factor that will bolster the demand for surface plasmon resonance. Imaging systems help in increasing throughput at a remarkable speed and with precise motion and consistency in report generation. Furthermore, the introduction of multifunctional products for improved outcomes is also expected to drive the growth of the surface plasmon resonance market over the forecast period.

The global surface plasmon resonance market is projected to reach a market value of US$ 770 Mn in 2019, increasing at a decent CAGR of 6% over the forecast period of 2019 – 2029.

“Increasing application of surface plasmon resonance in the field of drug discovery and medical imaging is contributing to the growth of the surface plasmon resonance market. Development of new technologies coupled with surface plasmon resonance, such as nanoparticle surface plasmon resonance and microfluidics, is playing an important role in the overall growth of the global surface plasmon resonance market.”

Key Takeaways of Surface Plasmon Resonance Market Study

  • The market share of imaging systems is evaluated to grow at a significant rate by the end of 2029, as these are the ideal solution for the analysis of label-free and multiplexed biomolecules.
  • Sales of surface plasmon resonance are envisaged to be higher in North America. Increasing adoption of imaging systems and biosensors in life science R&D is anticipated to boost the growth of the surface plasmon resonance market in the region.
  • Innovation while developing imaging software used in surface plasmon resonance for the analysis of kinetic parameters of biomolecular interactions is a key aspect for increasing the reproducibility of results. Companies are investing in R&D initiatives to introduce superior imaging devices with enhanced magnification, to observe the smallest deflection in the refractive index, thus aiding the growth of the surface plasmon resonance market.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-962

surface plasmon resonance market share by region

Adoption of Label-free Detection Technique for Analysis of Biomolecules

Detection of biological analytes through their physical properties is difficult. As a result, researchers rely on the addition of some sort of label to one or more of the analytes that need to be studied. Inclusion of this label for increasing specificity and accuracy has increased the cost of reagents and assays. To reduce assay cost and complexity while providing more qualitative information through labelled detection, adoption of the label-free detection technique such as surface plasmon resonance has increased, and is expected to fuel the growth of the global surface plasmon resonance market during the forecast period. The label-free detection technique simplifies the procedure by reducing the time and effort required for the development of the assay. Thus, increasing adoption of label-free detection techniques over labelled detection is expected to boost the growth of the global surface plasmon resonance market.

Want more insights?

The surface plasmon resonance market report, a new study by Future Market Insights, opines on the evolution of the global surface plasmon resonance market from 2014–2018, and presents demand projections for 2019–2029, on the basis of product type (imaging systems, sensor systems, and reagents), application (drug delivery, material science, and biosensors), and end user (academic and research institutes, food and beverage industry, biopharmaceutical companies, CROs, and others), across seven prominent regions.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-962

SURFACE PLASMON RESONANCE MARKET TAXONOMY

The global surface plasmon resonance market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Product Type

  • Imaging Systems
  • Sensor Systems
  • Reagents

Application

  • Drug Discovery
  • Material Science
  • Biosensors

End User

  • Academic & Research Institutes
  • Food & Beverage Industry
  • Biopharmaceutical Companies
  • CROs

Others

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-962

Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East and Africa

PD-L1 Biomarker Testing Market is expected to surge past valuation of US$ 2.05 billion by the end of the forecast period 2021-2030

As the prevalence of lung cancer, melanoma, and renal cell carcinoma continues to soar worldwide, the adoption of PD-L1 biomarker testing is expected to grow at a healthy pace in the years to come, says Future Market Insights (FMI) in its new market study. Moreover, the report forecasts that the global PD-L1 biomarker testing market will grow in value at a stellar CAGR of 13.1% between 2020 and 2030.

The report opines that the outbreak of COVID-19 is likely to create short-term fluctuations on the supply side due to pandemic-related issues such as workforce shortages and disruptions of delivery networks. Similarly, a steep decline in the number of tests has been observed during the pandemic, and this is expected to further decelerate the demand for PD-L1 biomarker testing.

The report primarily attributes the growth of the market to the increasing incidence of cancers, especially lung and skin, coupled with the development of advanced diagnostic kits and assays.

Likewise, rising awareness regarding the availability of testing methodology such as immunohistochemistry-based assays and Enzyme-linked Immunoassay (ELISA) based detection will continue to impel the adoption of PD-L1 biomarkers in the forthcoming years.

Key Takeaways

  • The global PD-L1 biomarkers testing market is expected to surge past valuation of US$ 2.05 Bn by the end of the forecast period.
  • PD-L1 SP142 assay kits will remain the most popular products among end-users, capturing nearly half of the market value, owing to high efficiency in detecting cancer tumors.
  • Non-small cell lung cancer and melanoma are cumulatively expected to hold more than 50% of the total market value on the back of the soaring prevalence of these diseases.
  • By end-use, PD-lL1 biomarker testing finds the majority of applications in hospitals, which is expected to account for over 60% of market value.
  • North America will spearhead the regional landscape through the forecast period, accounting for more than 50% of the global market value.
  • Europe is poised to remain the second most lucrative region, holding nearly 1/3rd of market value.

“Market players are directing their efforts towards improving the accessibility of these products and are marking them cost-effective to ensure wide-scale adoption,” remarks FMI analyst.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-5897

COVID-19 Impact on PD-L1 Biomarker Testing Market

The COVID-19 pandemic has created disruptions across the healthcare technology landscape and has resulted in a shifting preference among manufacturers towards essential technologies and treatments. Furthermore, although PD-L1 biomarker testing is used to test severe diseases such as cancer, a reduced number of screenings is adversely impacting the demand for testing.

For instance, according to trends observed by Cancer Research Network, screening rates of melanoma plummeted by approximately 50% in the UK in the past few months. Likewise, in the US, the number of tests conducted to detect non-small cell lung cancer fell by 30% in March as compared to February. As patients reschedule or skip regular screenings, this is creating a downtrend in demand for PL-D1 biomarker testing.

However, considering the severity of these diseases, the need for testing will swiftly arise in the future, ensuring that the market’s growth trajectory remains intact.

Who is Winning?

Key players operating in the market are focusing on enhancing existing product designs and developing novel products with increased accuracy. Moreover, traditional growth strategies such as acquisitions and mergers have been identified as strategies adopted by players to strengthen their foothold in the competitive landscape.

  • In January 2019, Abcam Plc acquired Calico Biolabs with an objective to expand its custom monoclonal production service capabilities.
  • In December 2018, NeoGenomics, Inc. acquired Genoptix, Inc. to improve its oncology diagnostic services.

FMI’s report includes profiles of some of the most prominent names in the market including F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., NeoGenomics Laboratories, Inc, HalioDx and Abcam plc. among others.

To Know More About PD-L1 Biomarkers Market

A new market research report published by Future Market Insights (FMI) on the global PD-L1 biomarkers market offers an executive-level blueprint of the market. It offers insights into demand trends and provides analysis of opportunities over the forecast period, 2020-2030. The report examines the market through four different segments – product, indication, end-use, and region. The report also provides extensive assessment of pricing by different key market dynamics, life cycle analysis, and technologies that are being deployed in the supply and product adoption across several end-use industries.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-5897

Key Segments

Product:

  • PD-L1 22C3 Assay Kit
  • PD-L1 28-8 Assay Kit
  • PD-L1 SP142 Assay Kit
  • PD-L1 SP263 Assay Kit

Indication:

  • Non-small Cell Lung Cancer (NSCLC)
  • Melanoma
  • Renal Cell Carcinoma
  • Gastrointestinal Tract Malignancies
  • Ovarian Cancer
  • Hematological Malignancies

End-user:

  • Hospitals
  • Diagnostic Laboratories
  • Specialty Clinics

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • Oceania
  • East Asia
  • Middle East and Africa

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-5897

Prescription Delivery Services Market expand staggeringly at a CAGR of 18.4% throughout the 2021-2030 forecast period, reaching a valuation of US$ 434.3 Million

Timely drug delivery is the cornerstone of an effective healthcare infrastructure. Rising prevalence of chronic and infectious ailments have accelerated production of prescription drugs, prompting vendors to develop effective distribution networks.

Advancements in consumer touch points and supply chains, including e-commerce, convenience stores and retail stores have greatly altered the prescription delivery services landscape. Advancements such as drone-based delivery and tracker based prescriptions are helping usher in smooth customer experience.

Furthermore, advanced prescription delivery systems have not only assisted in providing round-the-clock customer services but also helped manage dosage, therapy adherence and provide feedback to clinicians.

Prescription Delivery Services Market- Key Takeaways

  • Diabetic prescription drugs to hold major sway, poised to capture 36.7% market share by 2030
  • Ease of access to drugs addressing chronic conditions is slated to drive retail pharmacy growth to greater heights
  • North America to expand stupendously at a CAGR of 18.4% from 2020-2030, attributed to the presence of multiple convenience and pharmacy stores
  • Global prescription delivery services market to reach US$ 434.3 Mn by 2030-end

“Adoption of self-checkout kiosks and medicine dispensing machines shall enhance medicine purchasing experience of customers, permitting vendors to experience greater customer loyalty,” concludes the FMI analyst.

COVID-19 Impact Insights

The COVID-19 pandemic has generated fertile ground for the prescription delivery services market. The imposition of nationwide lockdowns to enforce social distancing have reduced footfalls across conventional pharmacies. This has compelled patients to rely on online retail platforms to avail their medicines.

Furthermore, heightened vulnerability of geriatrics suffering from co-morbidities to the coronavirus has necessitated stockpiling of essential medicines, thus keeping the need for prescription delivery services afloat throughout the pandemic’s duration. This panic buying behavior shall usher in an 80% y-o-y growth.

Growth is especially anticipated to be robust across the U.S, China and India, countries with the highest rates of infections. Collectively accounting for 40% of the global infection rate, these countries have witnessed an unprecedented increase in hoarding prescription medicines by individual households. This shall continue until the latter-half of 2021.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-12534

Market Witnessing Entry of e-Commerce Players

The Prescription Delivery Service Market is witnessing entry of e-Commerce, pharmacy and retail chains, albeit at a local or regional level. Technological developments, new product launches and collaborations characterize some critical expansion strategies of market players.

Some of the key players in the Prescription Delivery Service Market are: Walgreens Co., Walmart Stores Inc., CVS Health, Giant Eagle Inc., Express Scripts Holding Company, Ali Health and Kroger Co. to name a few.

Besides these established players, several startup companies are also emerging as potential game changers in the industry. These include NetMeds, Kfyao, Capsule, Myra Medicines, NURX, MedAvail, Zipdrug, Insightfil and ScriptDrop to name a few.

Walgreens, a prominent retail pharmaceutical distributor, has a robust presence in the global prescription delivery services market. The company offers refills, auto refills, drug information and home delivery services.

In 2017, the company acquired Rite Aid for a sum of US$ 5.2 billion, resulting in the merger of two of the United States’ three largest pharmacy chains.

More Insights on the Prescription Delivery Services Market

A recent market study published by Future Market Insights on the Prescription Delivery Services Market includes global industry analysis for 2015-2019 & opportunity assessment for 2020-2030, and delivers a comprehensive assessment of the most important market dynamics. The report has been segmented on the basis of disease indication (therapeutic drugs (diabetes, hypertension & cholesterol disorders), wellness supplements, OTC drugs and diagnostic drugs) and distribution channel (pharmacy stores, healthcare institutions, clinics and research institutions) across seven geographies (North America, Latin America, Europe, South Asia, East Asia, Oceania and MEA).

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-12534

Prescription Delivery Services Market Segmentation

Disease Indication

  • Therapeutic Drugs
  • Diabetes
  • Hypertension
  • Cholesterol Disorders
  • Wellness Supplements
  • OTC Drugs
  • Diagnostic Kits

Distribution Channel

  • Pharmacy Stores
  • Retail Pharmacy
  • Drug Stores
  • Healthcare Institutions
  • Clinics
  • Research Institutes

Region

  • North America (U.S & Canada)
  • Latin America (Brazil, Mexico & Rest of Latin America)
  • Europe (Germany, France, Italy, U.K, Spain, BENELUX, Russia & Rest of Europe)
  • South Asia (India, Malaysia, Thailand, Indonesia & Rest of South Asia)
  • East Asia (China, Japan & South Korea)
  • Oceania (Australia & New Zealand)
  • Middle East & Africa (GCC, Northern Africa, South Africa & Rest of MEA)

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-12534

Wearable Thermometers Market is set to witness robust growth with 8.9% CAGR growth during the year 2021-2031

According to the latest research by Future Market Insights, the wearable thermometers market is set to witness robust growth with 8.9% CAGR growth during the year 2021-2031.

The rising prevalence of Covid-19 cases in the world, which require thermometers to check the human body temperature, drives the wearable thermometers market demand. Increased consumer health awareness has led to wearable temperature sensors being used to efficiently measure health in the modern age.

In order to push the wearable thermometer market during its projected time, electronics integration and technological advancement adoption into everyday operations and changing lifestyles will also be anticipated.

What is Driving Demand for Wearable Thermometers Market

The growth of the market has been attributed to important factors, including the increasing prevalence of Covid-19 cases around the globe, growing demand for advanced monitoring devices to check body temperature, the widespread number of surgical procedures, the growing concern for children’s health in regions, and the growing demand for healthcare.

Furthermore, the key competitors in the market are witnessing the enormous development of research and development efforts to create new products and enhance existing goods.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-13941

The U.S. And Canada Wearable Thermometers Market Outlook

U.S and Canada are the main R&D player in the manufacture of wearable thermometers and the technological advancesment have encouraged the wearable thermometer to develop novel concepts. ?

Factors such as the growing incidents of chronic diseases, the increasing number of technological innovations, the presence of leading players, and the emerging new products in healthcare, etc. can be attributed to growth in the U.S. and Canada.

Additionally, U.S. and Canada is the largest contributor to the wearable wireless thermometer market, with a similar flow likely to continue and dominate the industry in the next several years.

Europe Demand Outlook for Wearable Thermometers Market

Europe’s fastest-growing market for wearable thermometer market continues and dominate the industry.

Factors such as the rising number of COVID-19 patients, geriatric population, development of new and advanced technologies, and increasing consciousness of innovative health services are the main reasons for the strong growth of the wearable thermometers market in Europe.

Additionally, the growing adoption of AI technologies by key manufacturers has boosted the demand outlook for wearable thermometers in Europe.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-13941

Who are the Key Manufacturers and Suppliers of Wearable Thermometers Market

Some of the key players operating in the wearable thermometers market are

  • Terumo Corporation
  • 3M Company
  • Drägerwerk AG & Co.
  • KGaA
  • Cosinuss GmbH
  • Welch Allyn, Inc.
  • Omron Healthcare
  • Microlife Corporation
  • Koninklijke Philips N.V.
  • Cosinuss
  • Masimo
  • Taidoc Technology Corporation
  • C.R. Bard
  • Helen of Troy Limited, and Briggs Healthcare.

Companies involve mergers, collaborations, and acquisitions aimed at enhancing their product portfolios, production capacity, and ensuring competitive variety.

For instance, In October 2020 the Medtech company Masimo announced that it is introducing for customers the Radius T continuous thermometer, a linked sensor system that can take a patient’s temperature over time, rather than manually.

If spikes occur in an application, the tool may also give temperature measurements and alarms. The alerts and notifications functionalities can be adjusted by users. The software can display both temperature and trend data in real-time.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors along with market attractiveness as per segments.

The report also maps the qualitative impact of various market factors on market segments and geographies.

 Wearable Thermometers Market Report Highlights:

  • Detailed overview of the parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

NOTE – All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company.

Key Segment

By Product Type:

  • In-Ear
  • Wristband/Watches
  • Medical Skin Patches
  • Smart Clothing
  • Others

By Application:

  • Clinical
  • Wellness

By Distribution Channel:

  • Institutional Sales
    • Hospitals
    • Clinics
    • Skilled Nursing Facilities
    • Long Term Care Centers
    • Ambulatory Care Centers
  • Retail Sales
    • Retail Pharmacies
    • Drug Stores
    • Online Sales

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-13941

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa

Stool Management Systems Market is expected to rise significantly, reaching value of USD$ 166.5 Million by the end of 2021

According to Future Market Insights (FMI), the demand for stool management systems is expected to rise significantly, reaching a market value of USD$ 166.5 Mn by the end of 2021.

Stool management systems are designed for bed ridden patients with fecal incontinence, a condition commonly known as bowel incontinence. These systems are used to prevent infections and reduce nursing time requirements.

The stool management systems are advantageous for older adults and patients suffering from constipation and fecal incontinence. Furthermore, it is also helpful for bed-ridden patients who may have been subject to aliments such as strokes, paralysis, or spinal injury.

According to the World Bank, approximately 700 million people were aged 65 and above in the world in 2019. Consequently, the overall high incidence of geriatric populations is resulting in the expansion of the patient pool and the resultant increase in the demand for stool management systems globally.

Fecal incontinence issues are common around the world and it has a notable burden on the economy and healthcare systems of society. The condition has impacted the economic system including hospital charges and nursing charges. Stool management systems help in reducing the nursing time and other hospital expenses.

Key players are focusing on strengthening their mergers and acquisition portfolios, in addition to advancement in technologies and new product launches. Europe holds the highest share in the market due to a vast target demographic, the presence of major market players, and high healthcare expenditure in the region.

Key Takeaways from Stool Management Systems Market Study

  • Systems are key to revenue generation in the stool management systems market surpassing accessories. They are likely to account for 63% value share by the end of the forecast period.
  • Luer-lock syringes will lead, with a valuation of over US$ 16 Bn by the end of 2021 owing to security in drug administration processes.
  • The U.S. accounts for more than 92% share in the North America market, and will witness growth backed by presence of a well-established healthcare sector.
  • Germany and France are leading countries in Europe and will account for more than 18% and 16% of the Europe market respectively in 2021.
  • Australia is the largest and fastest growing market in Oceania, exhibiting 6.2% CAGR during the forecast period.

“Increasing geriatric population, technological advancements, and a rising focus on next-gen stool management systems will create lucrative growth opportunities through 2031,” says the Future Market Insights analyst.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-3568

Who is Winning?

The global stool management systems market is set to expand due to the rising number of people suffering from stool related ailments. Leading organizations within the market are set to focus on research for healthcare systems to offer increasingly effective treatment options for superior patient outcomes.

Some of the leading players in the stool management systems market include B. Braun Melsungen AG, Becton Dickinson, ConvaTec, Inc., Hollister Incorporated, Prosyn International Ltd., Consure Medical and others.

Want More Insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels that provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global stool management systems market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the stool management systems market on basis of the product type in detail, cover every aspect of the market such as systems, accessories and major regions.

Stool Management Systems Market by CategoryProduct Type

  • Systems
    • External Management Systems
    • Indwelling Collection Systems
      • With Irrigation
      • Without Irrigation
  • Accessories
    • Catheter Tubes
    • Luer-Lock Syringe
    • Collection Bag with Filter
    • Clinch Clamp

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-3568

Region

  • North America
  • Europe
  • Oceania

Blood Warmer Devices Market is also estimated to bring in US$ 223.5 Million revenue by the end of 2026

According to a study by Future Market Insights (FMI), the global blood warmer devices market is anticipated to witness steady growth. The market is estimated to increase to 5.0% CAGR throughout the forecast period 2017-2026. Moreover, the market is also estimated to bring in US$ 223.5 million revenue by the end of 2026. Owing to the increasing incidence of trauma incidents, bypass surgeries, thyroid, orthopedic surgeries, and diabetes, the use of blood warming devices is also rising. The devices are also being used largely for treatment and prevention of complications such as hemorrhage and hypothermia. However, stringent government regulations and lack of awareness about the blood warming devices are some of the factors hampering the growth of the market.

Hypothermia has become very common and causes major complications, this is driving the demand for blood warmer devices. Since these devices can help in preventing complications during blood transfusion process the demand is expected to grow in the future. Companies are also investing in the research and development of portable and smart blood warming devices. Manufacturers are also working on new business strategies in order to launch a new product. Partnerships and collaborative activities are also on the rise. The demand for disposable blood and fluid warmer devices is also increasing, due to the rise in a number of complications.

Forecast Highlights on the Global Blood Warmer Devices Market

The global blood warmer devices market is segmented on the basis of end user, product type, application, and region. Based on the product type, the segment includes intravenous warming system, surface warming system and blood warming accessories. Among these, surface warming system is expected to be the widely accepted product in the global blood warmer devices market. By the end of 2026, surface warming system is estimated to surpass US$ 100 million revenue.

On the basis of end user, the segmentation consists of hospitals, blood banks, home care settings and others. Hospitals are expected to be the largest users of the blood warmer devices. By the end of 2017, hospitals are estimated to account for nearly two-third of the revenue share.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-5685

Based on the application, the market is segmented into home care, preoperative care, acute care, new born care and other application. Blood warming devices are expected to find the largest application in the preoperative care. By the end of 2026, preoperative care segment is estimated to reach nearly US$ 100 million revenue.

Geographically, the market is segmented into Europe, North America, Japan, Asia Pacific Excluding Japan (APEJ), the Middle East and Africa (MEA), and Latin America. Among these, North America is expected to dominate the global blood warmer devices market during the forecast period 2017-2026. Increasing occurrence of hypothermia among ageing population and infants in the U.S. is one of the factors driving the growth in North America. Growth in trauma cases and surgeries is also contributing towards the growth of the market in the region.

Key Market Player Competing to Sustain in the Market

The report offers a detailed profile of some of the key market players in the global blood warmer devices market such as 3M Company, Smiths Medical, The 37 Company, GE Healthcare, Emit Corporation, Stryker Corporation, Geratherm Medical, Barkey GmbH & Co. KG, Stihler Electronic GmbH, Biegler GmbH, Belmont Instrument, Keewell Medical Technology Co. Ltd., and Baxter International Inc. (Gambro). These key players are continuously working on new business strategies to offer better product and compete in the global market.

global blood warmer devices market

Market Taxonomy

Region

  • North America
  • Latin America
  • Europe
  • Japan
  • APEJ
  • MEA

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-5685

Product Type

  • Intravenous Warming System
  • Surface Warming System
  • Blood Warming Accessories

End User

  • Hospitals
  • Blood Banks
  • Home Care Settings
  • Other End Users

Application

  • Preoperative Care
  • Home Care
  • Acute Care
  • New Born Care
  • Other Applications

Microneedle Drug Delivery Systems Market Key Players – 3M Company, Becton, Dickinson and Company, Zosano Pharma Corporation, Raphas co. ltd., Nanopass Tech

Emerging applications of microneedle drug delivery systems are expected to fuel their demand over the next decade. According to a recent report published by Future Market Insights (FMI), the global microneedle drug delivery systems market will grow at a CAGR of 6.6% between 2020 and 2030. The market is witnessing surging demand in the field of pharmacy and cosmetics.

The rising incidence of diseases such as cancer, diabetes, migraine, and others and the need to accurately administer medications are driving the market. Additionally, the demand for minimally invasive and painless treatment methods is expected to bode well for the market.

The report uncovers hidden growth opportunities. It also highlights potential threats to the market players. Some of the key takeaways from the report are highlighted below.

Key Takeaways from the Report

  • Solid microneedles are expected to lead the market during forecast period of 2020-2030 among product type
  • Hospitals are the leading end users of microneedle drug delivery systems, with specialty clinics gaining popularity.
  • Specialty clinics are expected to grow at an accelerated rate as one of the key end users of microneedle drug delivery systems
  • North America is the largest market for microneedle drug delivery systems. Along with Europe, it is expected to cover more than 70% of the market by end of 2030.
  • East Asia is expected to be the fastest growing regional market during the next decade.

“Companies operating in the market are leaving no stone unturned to introduce innovations. Some have even tied up with leading solutions provider to commercialize their innovations once approved. This is expected to pave way for the market’s growth in the near future” said a lead Analyst at FMI.  

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-2750

Covid 19 Restricting Pace of Growth

The onset of pandemic has disturbed the entire business ecosystem. With productions coming to a halt and supply chains disrupted due to lack of transport, manufacturers of microneedle drug delivery systems are impacted in a big way.

Also, because of several restrictions by governments like social distancing, doctors and practitioners are choosing to avoid any surgical treatments which are not absolutely and immediately necessary.

Furthermore, cosmetic field which is another major user of microneedle drug delivery systems is also impacted as almost all treatments under their umbrella are considered to be not urgent.

The key market players in microneedle drug delivery systems market include the

3M Company, Becton, Dickinson and Company, Zosano Pharma Corporation, Raphas co. ltd., Nanopass Tech, Corium International, Inc., Valeritas, Inc., Nitto Denko Corporation, Microdermics, Inc., TheraJect Inc., Vaxxas Pty Ltd., Endoderma Ltd., QuadMedicine, SNvia Co., Ltd., Small Lab and AdminMed Nano BioSciences LLC

Consolidating their positions through mergers, acquisitions and new product launches, global microneedle drug delivery systems market players rely heavily on new product innovation and differentiation for gaining an edge over their competitors.

The market is poised to grow during the forecast period owing to the increasing cases of diseases and needle phobia among patients. However, changing regulatory dynamics are expected to affect the growth of microneedle drug delivery systems market in the future.

For instance, Zosano Pharma’s clinical trial of zolmitriptan with microneedle drug delivery system was stopped by U. S. Food and Drug Administration because inconsistencies were found in the drug delivery.

To Know More about Heat induction Cap liner Market:

Future Market Insights (FMI) brings the comprehensive research report on forecast revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global microneedle drug delivery systems market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on microneedle drug delivery systems market on the basis of product type such as solid microneedles, hollow microneedles and dissolving microneedles. Based on end-user such as hospitals, ambulatory centers, specialty clinics, academic institutes and research institutes across seven major regions

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2750

Key Segments

Product Type

  • Solid Microneedles
    • Silicon
    • Metal
    • Polymer
  • Hollow Microneedles
  • Dissolving Microneedles

End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Academic Institutions
  • Research institutes

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-2750

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • MEA